# A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer

> **NCT01874938** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 15 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **BIOLOGICAL:** LY2875358

## Key facts

- **NCT ID:** NCT01874938
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-08
- **Final completion:** 2014-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2015-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01874938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01874938, "A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01874938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*